Danimer Scientific (DNMR) Misses Q2 EPS by 11c, misses on revenue, provides outlook

Danimer Scientific (NYSE: DNMR) reported Q2 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $12.17 million versus the consensus estimate of $13.9 million.

Outlook

The Company noted that its second quarter and first half results have been consistent with its expectations, and it remains confident in its competitive position and its expectations for growth. At the same time, given a possible shift in the timing of certain significant new program awards and associated first shipment delays, the Company now believes that a bias toward the low end of its previously communicated range for 2023 full-year Adjusted EBITDA of $(23) million to $(31) million is prudent. The Company continues to anticipate full-year capital expenditures in the range of $26 million to $31 million.

For earnings history and earnings-related data on Danimer Scientific (DNMR) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c